HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Egon Urgard Selected Research

Egon Urgard Research Topics

Disease

3Inflammation (Inflammations)
01/2023 - 12/2020
2Infections
12/2022 - 01/2021
2Contact Dermatitis (Eczema, Contact)
12/2020 - 10/2016
2Skin Diseases (Skin Disease)
12/2020 - 10/2016
2Neoplasms (Cancer)
10/2017 - 01/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 01/2012
1Metaplasia
01/2023
1Hypersensitivity (Allergy)
01/2023
1Atrophy
12/2022
1Body Weight (Weight, Body)
12/2022
1Weight Loss (Weight Reduction)
12/2022
1COVID-19
12/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017
1Lung Neoplasms (Lung Cancer)
01/2017

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
12/2020 - 10/2016
2Interleukin-33IBA
01/2023 - 12/2020
2Cell-Penetrating PeptidesIBA
01/2021 - 12/2020
2InterferonsIBA
01/2021 - 01/2017
2ChemokinesIBA
01/2021 - 10/2016
2Irritants (Vesicants)IBA
12/2020 - 10/2016
2MicroRNAs (MicroRNA)IBA
12/2020 - 10/2017
2Interleukin-6 (Interleukin 6)IBA
12/2020 - 10/2016
1AntigensIBA
01/2023
1Immunoglobulin E (IgE)IBA
01/2023
1Immunoglobulins (Immunoglobulin)IBA
01/2023
1Immunoglobulin G (IgG)IBA
01/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022
1Green Fluorescent ProteinsIBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Therapeutic UsesIBA
12/2020
1Messenger RNA (mRNA)IBA
01/2017
1LigandsIBA
10/2016
1Biomarkers (Surrogate Marker)IBA
01/2012

Therapy/Procedure

1Intranasal Administration
01/2021
1Therapeutics
10/2016